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Pttenuation of the Negative Inotropic Effects
f Metoprolol at Short Cycle Lengths in Humans
omparison With Sotalol and Verapamil
ebecca H. Ritchie, BSC(HONS), PHD,*† Christopher J. Zeitz, MBBS, PHD, FRACP,*
onald D. Wuttke, BSC,* John T. Y. Hii, BMBS, FRACP,* John D. Horowitz, MBBS, PHD, FRACP*
delaide and Melbourne, Australia
OBJECTIVES This study sought to compare the influence of changes in systolic interval on the negative
inotropic effects of metoprolol, sotalol, and verapamil in patients with ischemic heart disease.
BACKGROUND The long-term symptomatic and prognostic effects of antiarrhythmic agents are not easily
predicted on the basis of acute hemodynamic actions at rest, but may be unmasked during
tachycardia. However, this has not been studied extensively in vivo.
METHODS The force-interval relationship of the intact human left ventricle was examined before and 10
min after intravenous bolus administration of the negatively inotropic agents metoprolol,
sotalol, or verapamil in patients undergoing diagnostic cardiac catheterization.
RESULTS All three drugs similarly reduced maximal rate of increase of left ventricular pressures
(LVdP/dtmax) by approximately 10%, but diversely modified the force-interval relationship.
The parameter c (the reduction in LVdP/dtmax of a fixed premature stimulus on mechanical
restitution) was significantly reduced by metoprolol (by 9 4%, p  0.05), was increased by
verapamil (by 6  2%, p  0.05), and was not significantly changed by sotalol. Similarly,
metoprolol had a minimal effect on the extent of frequency potentiation, whereas sotalol and
verapamil attenuated frequency potentiation (the relative response to 10 s of rapid pacing was 1.19
 0.58-fold, 0.07  0.35-fold, and 0.03  0.17-fold of the baseline response after 10 min of
metoprolol, sotalol, or verapamil, respectively).
CONCLUSIONS These results show that the negative inotropic effects of metoprolol are attenuated and those
of verapamil are accentuated at short cycle lengths; sotalol is intermediate between the two.
These properties may contribute to the relative safety of these agents in patients prone to
hemodynamic deterioration during sustained tachycardia. (J Am Coll Cardiol 2006;48:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.04.0921234–41) © 2006 by the American College of Cardiology Foundation
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snset of tachycardia in patients administered class I (sodium-
hannel blocker) or class IV (calcium-channel antagonist)
ntiarrhythmic drugs is associated with increased risk of
cute hemodynamic collapse, despite these agents being well
olerated in sinus rhythm (1,2). Changes in heart rate may
hus unmask negative inotropic effects of cardioactive drugs
ot apparent at rest, which may contribute to increased
ortality during treatment with such agents in patients with
mpaired left ventricular systolic function (3,4). Conversely,
lass II antiarrhythmic agents, beta-adrenoceptor antago-
ists, are not poorly tolerated at faster heart rates (5),
uggesting differential modulation of the force-frequency
elationship by antiarrhythmic agents.
The relationship between alterations in stimulation rate
nd myocardial contractile performance can be studied
sing either frequency potentiation and/or mechanical res-
itution. Frequency potentiation, also known as the staircase
r Treppe phenomenon, is commonly used in vitro (6,7),
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laide, Adelaide, Australia; and the †Baker Heart Research Institute, Melbourne,
ustralia. Supported by grants from the National Heart Foundation (Deakin,
CT, Australia) and the Merck Foundation (South Granville, NSW, Australia).
r. Ritchie was a University of Adelaide (Adelaide, SA, Australia) and Queen
lizabeth Hospital Research Foundation (Woodville, SA, Australia) Postgraduate
cholar. Dr. Zeitz was a National Heart Foundation Postgraduate Scholar.h
Manuscript received July 8, 2005; revised manuscript received February 23, 2006,
ccepted April 4, 2006.nd is illustrated by the incremental reductions in calcium-
hannel current and contractile force induced by verapamil
n vitro with progressive increases in stimulation frequency
8,9). However, the sustained tachycardia of frequency
otentiation in vivo may result in neurohumoral activation,
hanged loading conditions, ischemia, or even hemody-
amic deterioration (10–13). Such effects could distort the
orce-interval relationship, and thus limit utility of fre-
uency potentiation.
The force-interval relationship can also be examined
both in vitro and in vivo) using mechanical restitution
urves (MRC). Mechanical restitution is the recovery of
yocardial contractility after a non–steady-state beat (7).
e have recently described a mathematical model of the
RC that has proven highly reproducible in patients under
nvestigation for ischemic heart disease (14,15). In the
urrent investigation, we studied the acute effects of 3 phar-
acologically different antiarrhythmic agents on the force-
nterval relationship, metoprolol (a selective 1-adrenoceptor
ntagonist), d,l-sotalol (a nonselective -adrenoceptor antag-
nist with additional outward delayed rectifier potassium
urrent blocking properties) and verapamil (an L-type
alcium-channel antagonist). All three drugs elicit negative
notropic effects in sinus rhythm. Using both MRC con-
truction and frequency potentiation analysis, we tested the
ypothesis that the negative inotropic effects of metoprolol,
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-R interval in patients with ischemic heart disease. Although
revious data have suggested that the negative inotropic effects
f verapamil might be accentuated at higher stimulation
requencies (9,10), clinically based hemodynamic comparisons
f these agents have been lacking.
ETHODS
tudy population. Patients with stable symptoms were
elected from those undergoing routine diagnostic cardiac
atheterization and coronary arteriography for the investi-
ation of chest pain. Exclusion criteria included unstable
ngina pectoris, significant left main coronary artery steno-
is, electrocardiographic (ECG) evidence of abnormal con-
uction intervals, clinically significant valvular disease, re-
ent myocardial infarction (in the last 3 months), and severe
mpairment of left ventricular systolic function (ejection
raction 30%), in addition to clinically significant renal or
epatic disease. The protocol was approved by the Ethics of
uman Research Committee of The Queen Elizabeth
ospital, and prior informed consent was obtained.
atheterization protocol. Administration of all beta-
drenoceptor and calcium-channel antagonists was ceased at
east 5 half-lives before the study. Oral diazepam and
iphenhydramine were administered approximately 30 min
efore cardiac catheterization as premedication. Right and
eft cardiac catheterization and coronary arteriography were
erformed under local anesthesia (1% lidocaine) using the
udkins approach via femoral arterial (16) and venous
heaths. The research procedure commenced at the end of
he routine catheterization. A bipolar pacing lead was posi-
ioned in the right atrium, and a 4-F micromanometer-tipped
atheter (Millar Instruments, Houston, Texas) was inserted via
he femoral artery sheath into the left ventricle for measure-
ent of left ventricular pressure and maximal rate of increase of
eft ventricular pressures (LVdP/dtmax). A 7-F Swan-Ganz
atheter was positioned in the pulmonary artery for determi-
ation of cardiac output via thermodilution. Incremental
adiation exposure associated with the research procedure
as minimal, limited to screening to check Millar catheter
osition.
Patients underwent continuous baseline atrial pacing at a
ate 7  1% above spontaneous heart rate to maintain a
onstant heart rate throughout the procedure. Cardiac output
the average of at least three readings at each time point), mean
Abbreviations and Acronyms
CI  confidence interval
ECG  electrocardiographic
LVdP/dtmax  maximal rate of increase of left
ventricular pressures
MAP  mean arterial pressure
MRC  mechanical restitution curverterial pressure (MAP), ECG parameters, and left ventricular
r
Lressure and its first derivative LVdP/dtmax were recorded
ontinuously. After acquisition of baseline data, including
RC and frequency potentiation determination, patients
ere sequentially allocated to receive metoprolol (4 mg; n
5), sotalol (20 mg; n  15), or verapamil (4 mg; n  17)
s a rapid intravenous bolus. Sodium nitroprusside was also
nvestigated in an additional subgroup of patients (10 to 20
g/min intravenous infusion until approximately a 10%
eduction in MAP was observed, n  5) to determine the
nfluence, in isolation, of altered loading conditions on the
RC. The dose of each agent was chosen from the lower
nd of the dosage range used clinically. Hemodynamic
easurements and serial MRCs were obtained at frequent
ntervals up to 10 min after administration. Frequency
otentiation was re-examined at 10 min.
echanical restitution. The MRCs were constructed as
reviously described (14,15). Briefly, premature stimuli of
wice the threshold strength were inserted every 8 beats
uring baseline pacing, at progressively shorter R-R inter-
als, until refractoriness prevented impulse conduction. The
ontractile strength of each beat, LVdP/dtmax, was plotted
s a function of the R-R interval. The LVdP/dtmax was
xpressed as a percent of that observed in the drug-free state
uring baseline pacing, and R-R interval as a percent of the
ycle length of the baseline-pacing rate. This was then fitted to
ne-half of a rectangular hyperbolic function, described by:
y a c (100 d) (60 d) ⁄ 40 (x d)
here x is the R-R interval of the premature stimulus and y
s LVdP/dtmax. The horizontal and vertical asymptotes are
epresented by a and d, respectively. The parameter c, the
ifference between the calculated values of LVdP/dtmax
rom the fitted curve when the R-R interval is 100%, and
igure 1. A theoretical mechanical restitution curve (MRC): a (units are
ercent baseline LVdP/dtmax) and d (units are percent baseline R-R
nterval) represent the horizontal and vertical asymptotes, respectively; the
arameter c (units are percent baseline LVdP/dtmax) represents the
eduction in LVdP/dtmax with a 40% reduction in R-R interval (13).
VdP/dtmax  maximal rate of increase of left ventricular pressures.
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eductions in R-R interval for each patient (14). We then
alculated the change in the parameter c 10 min after
reatment by subtracting it from the pretreatment value, to
btain -parameter c. Thus, an increase in c after drug
dministration (i.e., positive -parameter c) would indicate
irectly rate-dependent negative inotropic effects.
requency potentiation. The force-interval relationship
as also assessed using frequency potentiation by determin-
ng the influence of 1 min of rapid pacing (34  2% above
he rate of baseline pacing) on LVdP/dtmax in 10-s
ntervals. This protocol was not performed in patients with
evere angina pectoris, and was precluded by the develop-
ent of atrioventricular block in some patients. We then
urther analyzed the frequency potentiation response by
xpressing the pacing-induced increase in LVdP/dtmax
fter drug administration in each patient as a ratio of the
esponse observed before treatment for each of metoprolol,
otalol, and verapamil to calculate the relative frequency
otentiation response.
tatistical analyses. Results were expressed as mean SE.
he goodness-of-fit of the MRC model for each individual
atient was determined using residual standard deviations.
onfidence intervals (Cis) at 95% were derived for these
tandard deviations. One-factor analysis of variance was
sed to compare patient characteristics at baseline in the
our groups, and with repeated measures analysis (Dunnett),
o examine the time course of LVdP/dtmax and c as
ppropriate. Paired t tests were used to compare the
emodynamic and ECG effects of the drugs studied, before
nd 10 min after injection. The differential effects of the
hree agents, metoprolol, verapamil, and sotalol, on MRC
nalysis were examined via one-way analysis of variance of
-parameter c across all three patient groups. To determine
hether the 3 agents attenuated the frequency potentiation
esponse, we compared the relative frequency potentiation
esponse across all three patient groups using a 1-way
nalysis of variance. Statistical significance was accepted at
he p  0.05 level.
ESULTS
atient characteristics. The clinical characteristics before
rug injection of all 52 patients studied are summarized in
able 1. The groups were generally well matched, with
redominantly normal left ventricular systolic function, and
Table 1. Patient Characteristics at Baseline
Met
(n
Age (yrs) 56
Gender (male/female) 1
Coronary disease* 10
Left ventricular ejection fraction (%) 63
Pulmonary capillary wedge pressure (mm Hg) 8
Paced relative risk interval (ms) 800*Greater than 50% stenosis in at least 1 coronary artery (left antero significant differences in characteristics between the
roups. Clinically significant coronary artery disease (steno-
is50% in at least 1 major branch of a coronary artery) was
resent in 36 patients. The procedure was well tolerated in
ll patients.
emodynamic effects during baseline pacing. The doses
or each of metoprolol, sotalol, and verapamil used in the
resent study were chosen with the intention of achieving
imilar negative inotropic effects at baseline pacing: the
hree negatively inotropic drugs induced approximately a
0% reduction in LVdP/dtmax (Fig. 2). Table 2 summa-
izes the hemodynamic and ECG effects of all drugs studied
uring baseline pacing, at the time of peak effect (10 min
fter drug injection for metoprolol, sotalol, and verapamil,
nd at the time of maximal hypotensive effect for sodium
itroprusside). The MAP was significantly reduced by both
erapamil and sodium nitroprusside (as a requirement of the
ength of the infusion period), but not by either metoprolol
r sotalol. Sodium nitroprusside had no additional hemo-
ynamic effects, although pulmonary capillary wedge pres-
ure also tended to decrease (from 13  2 mm Hg to 10 
mm Hg, p  NS).
orce-interval relationship. The influence of metoprolol,
otalol, and verapamil on the MRC is shown in Figure 3
efore and 10 min after injection (the time of peak effect).
he residual SDs of the model (the measure of goodness-
f-fit) for these drugs were 4.9 (95% CI 3.3 to 6.4), 5.1
95% CI 3.5 to 6.7), and 8.3 (95% CI 5.9 to 10.6; p  0.05
s. metoprolol and verapamil) for metoprolol, verapamil,
ol
)
Sotalol
(n  15)
Verapamil
(n  17)
Sodium Nitroprusside
(n  5)
54  2 61  3 61  6
10/5 9/8 1/4
) 11 (73%) 12 (71%) 3 (60%)
72  2 69  3 65  3
7  1 8  1 13  1
780  30 730  30 710  40
igure 2. Time course of changes in LVdP/dtmax (percent baseline)
nduced by metoprolol, sotalol, or verapamil during baseline pacing before
open bars), 5 min after (hatched bars), and 10 min after (solid bars)
njection. Asterisks indicate statistical significance compared with baseline
analysis of variance with repeated measures). Abbreviations as in Figure 1.oprol
 15
 2
1/4
(67%
 3
 1
 40ior descending, circumflex, or right coronary artery).
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September 19, 2006:1234–41 Negative Inotropes Modulate the Force-Interval Relationshipnd sotalol, respectively. Although all three drugs exerted a
imilar negative inotropic effect during baseline pacing (Fig.
), these effects differed on MRC analysis. Metoprolol
ecreased LVdP/dtmax by 12  3% during baseline
acing. However, this negative inotropic effect became less
arked at shorter R-R intervals, and was completely abolished
hen the R-R interval was reduced to 60%. On the fitted
RC, LVdP/dtmax was 72  4% and 70  3% at an R-R
nterval of 60% before and after metoprolol, respectively (Fig.
A). This was reflected by a significant reduction in c from
8  4% to 21  3% (Fig. 4A; p  0.05). In the group of
atients allocated to receive sotalol, LVdP/dtmax was
educed by 11  3% during baseline pacing. On MRC
nalysis, the negative inotropic effect of sotalol was virtually
able 2. Hemodynamic and Electrocardiographic Effects During
ffect (10 Min After Injection for Metoprolol, Sotalol, and Verap
odium Nitroprusside)
Metoprolol
Before After Befo
ardiac index (l/min/m2) 2.6  0.1 2.6  0.1 2.7 
ean arterial pressure (mm Hg) 101  4 103  3 109 
R interval (ms) 182  6 190  6* 193 
T interval (ms) 367  11 365  10 379 
VdP/dtmax (% baseline) 100  0 88  3* 100 
p  0.05 vs. before drug.
LVdP/dtmax  maximal rate of increase of left ventriclar pressures.
igure 3. Mechanical restitution curve (MRC) curve-fitting analysis for
epresentative raw and fitted data obtained from one patient in each grou
urve) drug administration. The right-hand panel shows mean data from
dministration. Abbreviations as in Figure 1.nchanged as the R-R interval decreased. The LVdP/
tmax on the fitted MRC was 72  6% and 59  7% at an
-R interval of 60% before and after sotalol, respectively
Fig. 3B), and c did not fluctuate significantly (from 29 
% to 31  7%, p  NS) (Fig. 4B). In contrast with
etoprolol and sotalol, verapamil tended to induce a diver-
ence of the MRC, with the negative inotropic effect (8 
% reduction in LVdP/dtmax at baseline) progressively
ccentuated as the R-R interval decreased. On the fitted
RC, LVdP/dtmax was 81 4% and 67 5% at an R-R
nterval of 60% before and after verapamil, respectively (Fig.
C). This corresponded to an increase in c from 18 4% at
aseline to 24 4%, indicative of a rate-dependent effect (p
0.05) (Fig. 4C). Moreover, when -parameter c after 10
line Atrial Pacing of Each Drug Studied, at Time of Peak
; Approximately 5 Min After Infusion Stopped for
talol Verapamil Sodium Nitroprusside
After Before After Before After
2.5  0.1 3.1  0.1 3.1  0.1 2.9  0.1 2.7  0.1
110  3 109  4 104  4* 117  11 105  9*
201  8* 210  8 215  9 186  19 182  18
386  7 356  8 360  6 370  7 370  9
89  3* 100  0 93  2* 100  0 95  4
etoprolol, (B) sotalol, and (C) verapamil. The left-hand panel shows
ore (closed circles, solid curve) and 10 min after (open circles, dashedBase
amil
So
re
0.1
3
9
8
0(A) m
p, befthe fitted MRC before (closed circles) and after (open circles) drug
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Negative Inotropes Modulate the Force-Interval Relationship September 19, 2006:1234–41in was compared among metoprolol, sotalol, and vera-
amil, the MRC response to metoprolol was significantly
ifferent than that obtained with verapamil (p  0.05) (Fig.
B). The significant decrease in MAP induced by sodium
itroprusside, however, was not accompanied by significant
lterations in LVdP/dtmax either during baseline pacing (5
4% vs. baseline, p  NS) or at shorter R-R intervals. No
ignificant fluctuations in the parameter c were observed
from 43  6% to 43  7%, p  NS, results not shown).
requency potentiation. The force-interval relationship
as also investigated using frequency potentiation analysis
efore and 10 min after administration of each of the three
egatively inotropic drugs. Figure 5 shows the time course
f LVdP/dtmax during rapid pacing. Before drug admin-
stration, the effects of rapid pacing were comparable in the
treatment groups, showing an initial increase of approxi-
ately 20% in LVdP/dtmax, which was preserved for the
ull minute. As with MRC analysis, all three agents exam-
ned showed different effects on the extent of frequency
otentiation (Fig. 5), especially evident after 10 s of rapid
acing. Metoprolol did not affect the frequency potentiation
esponse: the pacing-induced increases in LVdP/dtmax
efore and after the drug were maintained (Fig. 5A). This
as not the case for verapamil: the pacing-induced increase
n LVdP/dtmax seemed to be markedly suppressed during
he 1 min of rapid pacing (Fig. 5C). The results for sotalol
ere intermediate between those of metoprolol and vera-
amil (Fig. 5C). As shown in Figure 5D, the relative
igure 4. Time course of changes in the parameter c from mechanical rest
40% reduction in R-R interval from the fitted MRC model) for each o
ignificance compared with baseline (analysis of variance with repeated m
nduces a significantly different response to metoprolol (analysis of variancrequency potentiation response after metoprolol was un- ihanged after 10 s of rapid pacing; conversely, both sotalol
nd verapamil significantly attenuated the relative frequency
otentiation response (p  0.005). After 60 s of rapid
acing (at which time ischemia and/or neurohumoral acti-
ation may be evident [10,12]), sotalol, however, no longer
he attenuated the frequency potentiation response (results
ot shown).
ISCUSSION
he results of the current study show that the negative
notropic effects during tachycardia of a pharmacologically
eterogeneous group of antiarrhythmic drugs cannot be
redicted on the basis of their observed effects in the resting
tate. Metoprolol, sotalol and verapamil were administered
cutely at doses that elicited comparable negative inotropic
ffects at rest (Fig. 2) and minimal changes in pulmonary
apillary wedge pressure. However, these three agents ex-
rted markedly different negative inotropic effects at shorter
-R intervals, as determined from both MRC (Figs. 3 and
) and frequency potentiation analysis (Fig. 5). The negative
notropic effects of metoprolol were markedly attenuated at
hort cycle lengths on MRC analysis, and metoprolol did
ot attenuate the inotropic response associated with fre-
uency potentiation. Conversely, verapamil exerted directly
ate-dependent negative inotropic effects, virtually ablating
he frequency potentiation response; accentuation of vera-
amil’s negative inotropy was also evident at short R-R
n curve (MRC) curve-fitting analysis (the decrease in LVdP/dtmax with
metoprolol, (B) sotalol, and (C) verapamil. Asterisks indicate statistical
es). (D) The increment in parameter c after drug treatment. Verapamil
bbreviations as in Figure 1.itutio
f (A)ntervals on MRC analysis. The effects of sotalol were
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September 19, 2006:1234–41 Negative Inotropes Modulate the Force-Interval Relationshipntermediate between those of metoprolol and verapamil,
elatively independent of R-R interval on MRC analysis and
ome attenuation of the frequency potentiation response.
Construction of MRCs was the primary methodology
sed in the current study for the quantitative examination of
rug effects on the force-interval relationship. We have
reviously shown that this is highly reproducible, with
ignificant determinants of the parameter c including R-R
nterval (held constant in the present investigation) and left
entricular ejection fraction (14,15). Sodium nitroprusside,
sed in part because of the known insensitivity of the
orce-frequency relationship to nitric oxide (17), exerted no
ignificant effects on mechanical restitution, suggesting that
he parameter c is relatively independent of small changes in
reload and afterload. Nevertheless, it remains possible that
ifferential effects on preload might have influenced some of
he observed differences between verapamil and metoprolol/
otalol. The use of additional measures of the inotropic
tate, and in particular the simultaneous measurement of left
entricular pressure and volume, would have provided more
oad-independent assessment of drug effect. The reductions
n LVdP/dtmax induced by metoprolol and sotalol in the
resent study are consistent with previous investigations in
umans (18–21). However, we now show that the negative
notropic effect of metoprolol is reverse rate-dependent on
RC analysis. These data are consistent with recent sug-
estions that metoprolol normalizes the ventricular force-
requency relationship in patients with heart failure (5).
igure 5. Influence of negatively inotropic agents on frequency potentiati
VdP/dtmax during rapid pacing before (closed circles) and after (ope
bserved immediately before the onset of rapid pacing. (D) The relativ
VdP/dtmax after 10-s rapid pacing, observed 10 min after treatment as a
etoprolol) significantly attenuated the frequency potentiation response (aonversely, sotalol did not significantly influence MRC. olso on MRC analysis, we quantitatively showed that the
egative inotropic effect of verapamil was accentuated at
horter R-R intervals in humans in vivo. The rate-
ependent nature of this negative inotropic effect has been
learly defined in animal models in vitro (8,9). However, no
vidence of this type for verapamil or any other calcium
ntagonist in humans was previously available. Clinical
xperience with the acute administration of verapamil has
uggested the potential for acute hypotensive and negative
notropic sequelae (2,4), a complication that is rarely ob-
erved in the absence of tachyarrhythmias.
The most appropriate examination of the effects of all
hree agents on frequency potentiation is after 10 s of rapid
acing (Fig. 5D) because more prolonged tachycardia may
nduce ischemia (12) and/or neurohumoral activation (10)
n some patients. Nevertheless, the three agents examined
isparate effects on frequency potentiation irrespective of
he period of rapid pacing considered. Metoprolol had no
etectable effect, whereas verapamil significantly (and so-
alol to a lesser extent) impaired the frequency potentiation
esponse. These disparate effects of the agents examined
ay reflect the underlying physiological changes involved in
echanical restitution and frequency potentiation. Fre-
uency potentiation in an intact circulation represents a
omplex model comprising both negative (mechanical
estitution-like) and positive inotropic (Treppe-like) com-
onents. The cellular correlates of this model cannot be
scertained in the current setting. Nevertheless, the rank
r each of (A) metoprolol, (B) sotalol, and (C) verapamil. Time course of
les) drug injection. Results are expressed as a percent of LVdP/dtmax
uency potentiation (FP) response after drug treatment (the increase in
of the response observed previously). Both sotalol and verapamil (but not
is of variance). Abbreviations as in Figure 1.on fo
n circ
e freqrder of rate-related negative inotropic effects (verapamil 
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Negative Inotropes Modulate the Force-Interval Relationship September 19, 2006:1234–41otalol  metoprolol) was identical to that seen with MRC
nalysis. The incomplete MRC, the principal measure of
he force-interval relationship used in the present study,
eflects availability of calcium for contractile performance.
onventionally it has been regarded that a major determi-
ant of mechanical restitution at low stimulation frequen-
ies is calcium release from the sarcoplasmic reticulum,
hereas trans-sarcolemmal calcium flux becomes increas-
ngly important at high stimulation frequencies (8,9,22,23).
he diverse effects of metoprolol and verapamil at shorter
-R intervals observed in the current study may simply
eflect different sites of action on frequency-dependent
ellular physiology. The interaction between verapamil and
he L-type calcium channel per se is frequency-dependent:
he drug binds preferentially to its receptor when the
hannel is in the open state (8). No analogous cellular
henomenon has been observed for beta-adrenoceptor li-
ands. The major finding of attenuation of the negative
notropic effect of metoprolol at short cycle lengths is of
reat interest. Superficially, this is a somewhat paradoxical
bservation because previous studies in a range of myocar-
ial preparations (24) have suggested that the positive
notropic response to beta-adrenoceptor agonists increases
ith stimulation frequency. Available data for beta-
drenoceptor antagonists, however, are consistent with our
bservations: both chronic therapy of heart failure patients
ith metoprolol and acute propranolol treatment in intact
anine ventricles are associated with attenuated negative
notropic effects at increased heart rates (5,25).
The effects of sotalol on MRC and frequency potentia-
ion clearly differed from those of metoprolol in the present
tudy. The only previously reported investigation of sotalol
ffects in human ventricular myocardium (26) failed to show
ny effect of either d,l-sotalol or of d-sotalol (which lacks
ffects at the beta-adrenoceptor while retaining potassium-
hannel blockade), but the potential for rate-related inotro-
ic interactions was not examined. The results of the current
tudy imply that the potassium-channel blocking actions of
otalol modulate its inotropic effects, resulting in incremen-
al negative inotropy during tachycardia.
tudy limitations. This was essentially a study of patients
ith intact left ventricular systolic function (by nature of the
election criteria). It is possible that studying patients with
mpaired systolic function would produce different results
ith respect to the relationship between MRC and fre-
uency potentiation data: such patients might show an
nderlying defect of intracellular calcium availability
27,28), the consequences of which would increase progres-
ively as heart rate increased (29). Furthermore, we did not
nvestigate the mechanisms underlying the attenuation of
requency potentiation effects (attributed to progressive
nduction of ischemia and counter-regulatory neurohumoral
ctivation). The use of a pacing regimen that was sufficiently
rief as to be associated with no overt ischemia in any
atient clearly does not preclude the possibility that some
atients might have developed subclinical ischemia during theatter stages of the frequency potentiation protocol. On the
ther hand, it is unlikely that the abolition of bradycardia-
elated anti-ischemic effects (in the cases especially of meto-
rolol and sotalol) would have differentially influenced the
urrent results. Lastly, the potential for a correlation be-
ween changes in the force-interval relationship and simul-
aneous evaluation of cellular electrophysiology, difficult to
ccurately obtain in vivo, was not sought. Nevertheless, such
nformation might have provided additional insight, partic-
larly in the case of sotalol.
onclusions. In summary, we have shown that the nega-
ive inotropic effects of metoprolol are attenuated at short
ycle lengths. This would in theory be a salutary effect as
egards maintenance of hemodynamic status during tachy-
ardia, especially in the presence of impaired ventricular
unction, but might limit the effectiveness of the drug as an
ntianginal agent. Conversely, verapamil shows the poten-
ial for hemodynamic deterioration during tachycardia in
usceptible individuals. This may limit its utility in patients
ith angina plus left ventricular dysfunction (30). Hetero-
eneity between effects of metoprolol and sotalol may also
e important, illustrated by the deleterious effects of
-sotalol (31). Furthermore, the methodology used in this
tudy might well prove useful both during preclinical studies
nd in phase 1 human investigations of new cardioactive
gents to identify potential for hemodynamic deterioration
uring tachycardia.
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